HepCBC is a non-profit organization run by and for people infected and affected by hepatitis C.
Our mission is to provide education, prevention and support to those living with HCV.

HepCBC News

Treatment News

HCV Phase III Studies and Approved Agents
HCV Phase III Studies and Approved Agents
MK-5172 Plus PegIFN/RBV Achieves 86% to 92% SVR24 Rates in Treatment-Naive, Noncirrhotic Patients With Genotype 1 HCV
Vaniprevir Plus PegIFN/RBV Significantly Increases SVR24 Rate vs PegIFN/RBV Retreatment in Cirrhotic, Genotype 1 HCV–Infected, Previous Nonresponders to PegIFN/RBV
High SVR12 Rates With Short-Course (6 or 12 Weeks) of Ledipasvir and GS-9451 Plus PegIFN/RBV Quadruple Therapy in Treatment-Naive, Noncirrhotic Patients With Genotype 1 HCV Infection and IL28B CC Genotype

Personal Stories

Through HCV treatment many times:
I was diagnosed with hepatitis C back in 1991. I was tired of having stomach and intestinal problems all the
Read More
Mary Taylor More:
Replace Mary's photo and story with your own. Submit it to HepCBC and if it looks appropriate for this
Read More

READ MORE STORIES SHARE YOUR STORY

Videos

VISIT OUR YOUTUBE CHANNEL

Thanks to our Sponsors

This website re-design was generously made possible through the financial support of Merck Canada Inc. and Hoffmann-La Roche Ltd.